Novel transcript, antisense to peroxisome proliferator-activated receptor alpha (ENSG00000310070)

Natural antisense transcripts (NATs) like this molecule are noncoding RNAs transcribed from the DNA strand opposite a protein-coding gene, in this case, PPARA[4]. These transcripts can modulate the expression of their associated sense gene by various mechanisms, including transcriptional interference, chromatin remodeling, RNA masking, and RNA interference[2][3][4]. Experimental evidence from broader studies on NATs suggests that antisense transcripts may change the stability, processing, and transcription dynamics of sense transcripts, often leading to altered chromatin marks and potentially fine-tuned gene regulation[1][2]. However, there is currently no published evidence that this specific antisense transcript has a direct therapeutic role, disease causality, or is used as a drug target or biomarker. Its potential biological significance lies in its capacity to regulate PPARA gene expression, which is central to metabolic regulation, but no direct disease or drug associations have been described for this specific transcript. If further research uncovers more specific roles or clinical relevance for this transcript, these fields can be updated accordingly.

Other names

LOC105373074ENSG00000310070novel transcript, antisense to PPARA